MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Biomanufacturing, the contract development and manufacturing division of Therapure Biopharma Inc., announces that it has received The CMO Leadership Individual Attribute awards in four areas: Strength of Science, State of the Art, Accessible Senior Management and Cultural Fit.
The Life Science Leader’s annual CMO Leadership Awards Ceremony was held March 22, 2017 in New York City with winners chosen based on Industry Standard Research’s (ISR’s) Biologic API Contract Manufacturer Quality Benchmarking report. The CMO Leadership Awards ensure that quality ratings come from companies that have worked with the CMO/CDMO within the last 18 months and that results are based on experiential data.
"Each year, the CMO Leadership Awards recognize the success that individual drug development and manufacturing organizations have in serving the needs of their biotechnology and pharmaceutical customers and partners," said Louis Garguilo, executive editor of Life Science Leader magazine and OutsourcedPharma.com. "An award in any of the categories adds to the distinction and reputation of CMOs within the greater drug discovery, development, manufacturing and marketing industries."
“We are honoured and pleased to be recognized by our clients for capabilities and staff characteristic,” says Therapure’s President and CEO, Nick Green. “This achievement is only possible through the continued diligence of our employees, who are passionate about developing and manufacturing the highest quality biotherapeutics for our clients and their patients. That said, this is more than an award, it provides us with client feedback that helps us manage and improve the client’s experience throughout our organization.”
About Therapure Biomanufacturing
Therapure Biomanufacturing is a global contract development and manufacturing organization (CDMO) offering integrated services for developing, manufacturing, purifying and packaging complex biological therapeutics. Its scientific and manufacturing expertise, as well as its flexible, state-of-the-art cGMP facility, provides clients with optimal biomanufacturing solutions to advance their biotherapeutics from discovery to market.
For more information on our CDMO services, please visit http://www.therapurebio.com/CDMO/.
About Therapure Biopharma Inc.
Therapure Biopharma Inc. is an integrated biopharmaceutical company focused on complex biological therapeutics and technologies that can provide new options for patient care. Therapure Biopharma Inc. has two divisions: Therapure Biomanufacturing and Therapure Innovations, its drug discovery and development division. Therapure Biopharma Inc. operates out of two facilities located in Mississauga: a 130,000 sq. ft. cGMP facility that includes biomanufacturing, research and quality control laboratories and is built to meet FDA (US), HPFB (Canada), EMA (Europe) and MHRA (UK) standards, and a new 43,000 sq. ft. facility housing 30,000 sq. ft. of cGMP warehouse.
For more information on Therapure Biopharma Inc., please visit www.therapurebio.com